AN2 Therapeutics ANTX
NASDAQ ANTX
$3.64 +0.04 (+1.11%)
At close: Oct 22, 2026 · 4:00 PM EDT

AN2 Therapeutics (ANTX) Other non-cash items (2022 - 2023)

Updated

Analysis

AN2 Therapeutics (ANTX) Other non-cash items (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 AN2 Therapeutics 132.16 Mn -151.45 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 13,000.00
Jun 30, 2023 21,000.00
Mar 31, 2023 19,000.00
Dec 31, 2022 20,000.00
Sep 30, 2022 20,000.00
Jun 30, 2022 19,000.00
Mar 31, 2022 18,000.00
API Access

AN2 Therapeutics Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=ANTX&period=max&api_key=YOUR_API_KEY